Quarterly report pursuant to Section 13 or 15(d)

Condensed Statement of Cash Flows (Unaudited)

v3.19.3
Condensed Statement of Cash Flows (Unaudited)
 9 Months Ended
Sep. 30, 2019
USD ($)
Cash Flows from Operating Activities:  
Net income $ 2,775,921
Adjustments to reconcile net income to net cash used in operating activities:  
Unrealized gain on marketable securities held in Trust Account (31,696)
Interest earned on marketable securities held in Trust Account (2,970,867)
Changes in operating assets and liabilities:  
Prepaid expenses (64,340)
Accrued expenses 15,000
Net cash used in operating activities (275,982)
Cash Flows from Investing Activities:  
Investment of cash in Trust Account (300,000,000)
Net cash used in investing activities (300,000,000)
Cash Flows from Financing Activities:  
Proceeds from sale of Units, net of underwriting discounts paid 294,780,000
Proceeds from sale of Private Placement Warrants 6,750,000
Proceeds from issuance of Class B ordinary shares to Sponsor 25,000
Proceeds from promissory note - related party 274,178
Repayment of promissory note – related party (274,178)
Payment of offering costs (114,355)
Net cash provided by financing activities 301,440,645
Net Change in Cash 1,164,663
Cash - Beginning
Cash - Ending 1,164,663
Non-Cash Investing and Financing Activities:  
Initial classification of ordinary shares subject to possible redemption 285,145,870
Change in value of ordinary shares subject to possible redemption 2,790,695
Deferred underwriting fee $ 11,280,000